Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line

Eribulin is a new drug to treat soft tissue sarcoma (STS) that exerts antitumor activity by binding to microtubules. The prognosis of STS is poor, and eribulin is expected to improve the treatment outcome. We observed several cases that exhibited resistance to eribulin and developed an eribulin-resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yahiro, Kenichiro, Matsumoto, Yoshihiro, Fukushi, Jun-ichi, Kawaguchi, Ken-ichi, Endo, Makoto, Setsu, Nokitaka, IIda, Keiichiro, Fukushima, Suguru, Nakagawa, Makoto, Kimura, Atsushi, Oda, Yoshinao, Nakashima, Yasuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033248/
https://www.ncbi.nlm.nih.gov/pubmed/30034996
http://dx.doi.org/10.1155/2018/8987568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033248/
https://www.ncbi.nlm.nih.gov/pubmed/30034996
http://dx.doi.org/10.1155/2018/8987568

Ejemplares similares